REQUEST A DEMO
Total
USD $0.00
Search more companies

Enimmune Corporation (安特罗生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Enimmune Corporation Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Enimmune Corporation (安特罗生物科技股份有限公司) is an enterprise located in Taiwan, China, with the main office in Taipei City. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Enimmune Corporation (安特罗生物科技股份有限公司) was incorporated on January 10, 2014. It currently has a total number of 34 (2023) employees. From the latest financial highlights, Enimmune Corporation (安特罗生物科技股份有限公司) reported a net sales revenue increase of 11.4% in Q2C2025. There was a total negative growth of 34.11% in Enimmune Corporation (安特罗生物科技股份有限公司)’s total assets over the same period. The net profit margin of Enimmune Corporation (安特罗生物科技股份有限公司) increased by 35.3% in 2025.

Headquarters
18F.-2, No. 76, Sec. 2, Dunhua S. Rd., Da'An Dist
Taipei City; Taipei City;

Contact Details: Purchase the Enimmune Corporation (安特罗生物科技股份有限公司) report to view the information.

Website: http://www.enimmune.com.tw

Basic Information
Total Employees:
Purchase the Enimmune Corporation (安特罗生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Enimmune Corporation (安特罗生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Enimmune Corporation (安特罗生物科技股份有限公司) report to view the information.
Incorporation Date:
January 10, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50.26%
Purchase this report to view the information.
2.09%
Purchase this report to view the information.
1.78%
Purchase this report to view the information.
1.67%
Purchase this report to view the information.
1.48%
Subsidiaries
Enimmune-Rmt Biotech Pte.Ltd. (Singapore)
55%
Company Performance
Financial values in the chart are available after Enimmune Corporation (安特罗生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
11.4%
Total Operating Revenue
81.92%
Operating Profit
-4.68%
EBITDA
-30.64%
Net Profit/Loss for the Period
-2.56%
Total Assets
-34.11%
Total Equity
-59.22%
Operating Profit Margin
26.63%
Net Profit Margin
35.3%
Return on Equity (ROE)
-24.88%
Debt / Equity
55741%
Quick Ratio
-1398.93%
Cash Ratio
-1.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?